Cargando…

The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis

BACKGROUND: β-Amyloid (Aβ) plays a central role in Alzheimer's disease (AD) pathogenesis. Neurons are major sources of Aβ in the brain. However, astrocytes outnumber neurons by at least five-fold. Thus, even a small level of astrocytic Aβ production could make a significant contribution to Aβ b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jie, O'Connor, Tracy, Vassar, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216000/
https://www.ncbi.nlm.nih.gov/pubmed/22047170
http://dx.doi.org/10.1186/1742-2094-8-150
_version_ 1782216456658747392
author Zhao, Jie
O'Connor, Tracy
Vassar, Robert
author_facet Zhao, Jie
O'Connor, Tracy
Vassar, Robert
author_sort Zhao, Jie
collection PubMed
description BACKGROUND: β-Amyloid (Aβ) plays a central role in Alzheimer's disease (AD) pathogenesis. Neurons are major sources of Aβ in the brain. However, astrocytes outnumber neurons by at least five-fold. Thus, even a small level of astrocytic Aβ production could make a significant contribution to Aβ burden in AD. Moreover, activated astrocytes may increase Aβ generation. β-Site APP cleaving enzyme 1 (BACE1) cleavage of amyloid precursor protein (APP) initiates Aβ production. Here, we explored whether pro-inflammatory cytokines or Aβ42 would increase astrocytic levels of BACE1, APP, and β-secretase processing, implying a feed-forward mechanism of astrocytic Aβ production. METHODS: Mouse primary astrocytes were treated with combinations of LPS, TNF-α, IFN-γ, and IL-1β and analyzed by immunoblot and ELISA for endogenous BACE1, APP, and secreted Aβ40 levels. Inhibition of JAK and iNOS signaling in TNF-α+IFN-γ-stimulated astrocytes was also analyzed. In addition, C57BL/6J or Tg2576 mouse astrocytes were treated with oligomeric or fibrillar Aβ42 and analyzed by immunoblot for levels of BACE1, APP, and APPsβsw. Astrocytic BACE1 and APP mRNA levels were measured by TaqMan RT-PCR. RESULTS: TNF-α+IFN-γ stimulation significantly increased levels of astrocytic BACE1, APP, and secreted Aβ40. BACE1 and APP elevations were post-transcriptional at early time-points, but became transcriptional with longer TNF-α+IFN-γ treatment. Despite a ~4-fold increase in astrocytic BACE1 protein level following TNF-α+IFN-γ stimulation, BACE1 mRNA level was significantly decreased suggesting a post-transcriptional mechanism. Inhibition of iNOS and JAK did not reduce TNF-α+IFN-γ-stimulated elevation of astrocytic BACE1, APP, and Aβ40, except that JAK inhibition blocked the APP increase. Finally, oligomeric and fibrillar Aβ42 dramatically increased levels of astrocytic BACE1, APP, and APPsβsw through transcriptional mechanisms, at least in part. CONCLUSIONS: Cytokines including TNF-α+IFN-γ increase levels of endogenous BACE1, APP, and Aβ and stimulate amyloidogenic APP processing in astrocytes. Oligomeric and fibrillar Aβ42 also increase levels of astrocytic BACE1, APP, and β-secretase processing. Together, our results suggest a cytokine- and Aβ42-driven feed-forward mechanism that promotes astrocytic Aβ production. Given that astrocytes greatly outnumber neurons, activated astrocytes may represent significant sources of Aβ during neuroinflammation in AD.
format Online
Article
Text
id pubmed-3216000
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32160002011-11-16 The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis Zhao, Jie O'Connor, Tracy Vassar, Robert J Neuroinflammation Research BACKGROUND: β-Amyloid (Aβ) plays a central role in Alzheimer's disease (AD) pathogenesis. Neurons are major sources of Aβ in the brain. However, astrocytes outnumber neurons by at least five-fold. Thus, even a small level of astrocytic Aβ production could make a significant contribution to Aβ burden in AD. Moreover, activated astrocytes may increase Aβ generation. β-Site APP cleaving enzyme 1 (BACE1) cleavage of amyloid precursor protein (APP) initiates Aβ production. Here, we explored whether pro-inflammatory cytokines or Aβ42 would increase astrocytic levels of BACE1, APP, and β-secretase processing, implying a feed-forward mechanism of astrocytic Aβ production. METHODS: Mouse primary astrocytes were treated with combinations of LPS, TNF-α, IFN-γ, and IL-1β and analyzed by immunoblot and ELISA for endogenous BACE1, APP, and secreted Aβ40 levels. Inhibition of JAK and iNOS signaling in TNF-α+IFN-γ-stimulated astrocytes was also analyzed. In addition, C57BL/6J or Tg2576 mouse astrocytes were treated with oligomeric or fibrillar Aβ42 and analyzed by immunoblot for levels of BACE1, APP, and APPsβsw. Astrocytic BACE1 and APP mRNA levels were measured by TaqMan RT-PCR. RESULTS: TNF-α+IFN-γ stimulation significantly increased levels of astrocytic BACE1, APP, and secreted Aβ40. BACE1 and APP elevations were post-transcriptional at early time-points, but became transcriptional with longer TNF-α+IFN-γ treatment. Despite a ~4-fold increase in astrocytic BACE1 protein level following TNF-α+IFN-γ stimulation, BACE1 mRNA level was significantly decreased suggesting a post-transcriptional mechanism. Inhibition of iNOS and JAK did not reduce TNF-α+IFN-γ-stimulated elevation of astrocytic BACE1, APP, and Aβ40, except that JAK inhibition blocked the APP increase. Finally, oligomeric and fibrillar Aβ42 dramatically increased levels of astrocytic BACE1, APP, and APPsβsw through transcriptional mechanisms, at least in part. CONCLUSIONS: Cytokines including TNF-α+IFN-γ increase levels of endogenous BACE1, APP, and Aβ and stimulate amyloidogenic APP processing in astrocytes. Oligomeric and fibrillar Aβ42 also increase levels of astrocytic BACE1, APP, and β-secretase processing. Together, our results suggest a cytokine- and Aβ42-driven feed-forward mechanism that promotes astrocytic Aβ production. Given that astrocytes greatly outnumber neurons, activated astrocytes may represent significant sources of Aβ during neuroinflammation in AD. BioMed Central 2011-11-02 /pmc/articles/PMC3216000/ /pubmed/22047170 http://dx.doi.org/10.1186/1742-2094-8-150 Text en Copyright ©2011 Zhao et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhao, Jie
O'Connor, Tracy
Vassar, Robert
The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
title The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
title_full The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
title_fullStr The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
title_full_unstemmed The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
title_short The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
title_sort contribution of activated astrocytes to aβ production: implications for alzheimer's disease pathogenesis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216000/
https://www.ncbi.nlm.nih.gov/pubmed/22047170
http://dx.doi.org/10.1186/1742-2094-8-150
work_keys_str_mv AT zhaojie thecontributionofactivatedastrocytestoabproductionimplicationsforalzheimersdiseasepathogenesis
AT oconnortracy thecontributionofactivatedastrocytestoabproductionimplicationsforalzheimersdiseasepathogenesis
AT vassarrobert thecontributionofactivatedastrocytestoabproductionimplicationsforalzheimersdiseasepathogenesis
AT zhaojie contributionofactivatedastrocytestoabproductionimplicationsforalzheimersdiseasepathogenesis
AT oconnortracy contributionofactivatedastrocytestoabproductionimplicationsforalzheimersdiseasepathogenesis
AT vassarrobert contributionofactivatedastrocytestoabproductionimplicationsforalzheimersdiseasepathogenesis